Head-to-head · free
SOPHiA GENETICS S.A. vs Tempus AI, Inc.
SOPH vs TEM — return on capital, cash generation, margins and balance sheet side by side.
SOPH
1 / 4
measures where SOPH leads
TEM
3 / 4
measures where TEM leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | SOPH | TEM · FY2025 |
|---|---|---|
| Revenue | — | $1.3B |
| Net income | — | (245.0M) |
| Revenue growth (yearly, multi-year) | — | 83.4% |
| Free cash flow | — | (239.1M) |
| Free cash flow margin | — | -18.8% |
| Net cash / (debt) | — | — |
| ROIC | — | — |
| Return on equity | -110.0% | -89.5% |
| Gross margin | 67.4% | 62.7% |
| Operating margin | -91.8% | -19.9% |
| Net debt / EBITDA | 0.37x | -4.22x |
Figures are as reported by each company; latest fiscal year shown.
Where Tempus AI, Inc.'s cash went (FY2025)
- Capital spending
- $21.0M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free